Psyence Group Inc. (CSE:PSYG)

Canada flag Canada · Delayed Price · Currency is CAD
0.1500
0.00 (0.00%)
Oct 9, 2025, 11:22 AM EDT
Market Cap2.35M
Revenue (ttm)n/a
Net Income (ttm)-13.36M
Shares Out15.64M
EPS (ttm)-1.31
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,000
Average Volume942
Open0.1500
Previous Close0.1500
Day's Range0.1500 - 0.1500
52-Week Range0.0989 - 0.2476
Beta1.24
RSI42.94
Earnings DateNov 28, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, c... [Read more]

Sector Healthcare
Founded 2019
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol PSYG
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.